Research Topics
| J David BeattySummaryAffiliation: Swedish Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Standardized evaluation of regional and institutional breast cancer outcomesJ David Beatty
Department of Surgery, Swedish Cancer Institute, Seattle, WA, USA
Am J Surg 195:636-40; discussion 640. 2008..Optimal breast cancer control outcomes include early diagnosis, thorough staging work-up, and lowest disease-related mortality...
Metaplastic breast cancer: clinical significanceJ David Beatty
Department of Surgery, Swedish Cancer Institute, Suite 400, 1221 Madison Street, Seattle, WA 98104, USA
Am J Surg 191:657-64. 2006....
Utilization of cancer registry data for monitoring quality of careJ David Beatty
Department of Surgery, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
Am J Surg 201:645-9. 2011..The long-term goal is the use of cancer registry data for real-time interventions to optimize the process of individual patient multidisciplinary care...
The utility of intraoperative evaluation of sentinel lymph nodes in breast cancerMatthew S Pugliese
Department of Surgery, Comprehensive Breast Cancer Program, Swedish Cancer Institute, 1221 Madison Street, Suite 400, Seattle, Washington, USA
Ann Surg Oncol 14:1024-30. 2007..In breast cancer treatment, intraoperative sentinel lymph node (SLN) evaluation is used to identify patients who may potentially benefit from immediate completion of axillary lymph node dissection...
Contrast-enhanced breast magnetic resonance imaging: the surgical perspectiveJ David Beatty
Department of Surgery, Comprehensive Breast Cancer Program, Swedish Cancer Institute, 1221 Madison St, Suite 400, Seattle, WA 98104, USA
Am J Surg 193:600-5; discussion 605. 2007..Contrast-enhanced breast magnetic resonance imaging (MRI) has shown excellent sensitivity (93%) for breast malignancies. The clinical role and value of MRI for the breast surgeon remains unresolved and controversial...
Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancerJ David Beatty
Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
Am J Surg 197:637-41; discussion 641-2. 2009..This study examines the downstaging of breast cancer axillary lymph node (ALN) metastasis by neoadjuvant chemotherapy (NCT) and the potential facilitation of axillary-conserving surgery...
Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodesAngie R Taras
Swedish Cancer Institute, Swedish Medical Center, 1221 Madison Ave, Suite 400, Seattle, WA 98104, USA
Am J Surg 199:625-8. 2010..We examined the effect of false-negative SLN biopsy on breast cancer treatments and recurrence rate...
Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categoriesMatthew S Pugliese
Surgical Residency, Swedish Medical Center, 747 Broad Way, Seattle, WA 98122, USA
Ann Surg Oncol 16:113-20. 2009..However, the clinical significance of these categories is debated in the literature...
Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breastAngie R Taras
Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
Am J Surg 197:643-6; discussion 646-7. 2009..Intraoperative evaluation (IE) of SLNs facilitates immediate ALND. Controversy exists regarding the accuracy of intraoperative SLN evaluation for patients with invasive lobular carcinoma (ILC) compared to invasive ductal carcinoma (IDC)...
Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancerMatthew S Pugliese
Department of Surgery, Comprehensive Breast Cancer Program, Swedish Cancer Institute, Seattle, WA, USA
Am J Surg 192:516-9. 2006..IC allowed 49 (55%) of these patients to undergo synchronous completion of ALND. No unnecessary completion ALNDs were performed. The sensitivity of IC decreased with decreasing size of the metastasis...
Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survivalLisa M Precht
Swedish Cancer Institute, Swedish Medical Center, Seattle, Washington, USA
Breast J 16:362-8. 2010..For both HR- and HR+, addition of NAT for HER2+ tumors results in both a superior response and outcome...
Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced diseaseAngie R Taras
Department of Surgery, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA 98104, USA
Am J Surg 201:605-10. 2011..Current guidelines recommend postmastectomy irradiation (PMI) for patients with tumors >5 cm and/or ≥4 positive lymph nodes. This study evaluates the effect of PMI on recurrence and survival within tumor size and node status groups...
Positron emission mammography (PEM): effect of activity concentration, object size, and object contrast on phantom lesion detectionLawrence R MacDonald
Department of Radiology, University of Washington, Seattle, WA 98195, USA
Med Phys 39:6499-508. 2012..To characterize the relationship between lesion detection sensitivity and injected activity as a function of lesion size and contrast on the PEM (positron emission mammography) Flex Solo II scanner using phantom experiments...
Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDGCarolyn L Wang
1Seattle Nuclear Medicine Swedish Cancer Institute, 1229 Madison St, Ste 1050, Seattle, WA 98104 3306, USA
AJR Am J Roentgenol 197:W247-55. 2011..We also evaluated for the correlation between maximum uptake value on PEM and maximum uptake value on a whole-body PET/CT...
Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detectionMichel Schummer
Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
PLoS ONE 5:e9122. 2010....
Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breastJaggi Rao
Division of Dermatology and Cutaneous Sciences, University of Alberta, Edmonton, Canada
J Am Acad Dermatol 49:532-8. 2003..Treatment should be aggressive and include local surgery with consideration of adjuvant systemic chemotherapy...
